thanks Apse. you seemed to be quite knowledgeable with company information.
you have answered the question in 2nd point- "lock down big pharma partnerships on nanocelle". This is core business model of all DRUG DELIVERY PLATFORM companies - the ultimate dream.
offcourse MDC can pursue other interests but validate that nanocelle can stand within mass market first and secure some solid revenue stream.
- Forums
- ASX - By Stock
- MDC
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-28
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MDC (ASX) to my watchlist
|
|||||
Last
$6.60 |
Change
0.000(0.00%) |
Mkt cap ! $15.07M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
MDC (ASX) Chart |
Day chart unavailable
The Watchlist
CC9
CHARIOT CORPORATION LTD
MD - Shanthar Pathmanathan, Geologist - David Trabert
MD - Shanthar Pathmanathan
Geologist - David Trabert
SPONSORED BY The Market Online